Tiny study compares pill vs nasal spray drug absorption
NCT ID NCT06074016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looked at how the migraine drug zolmitriptan behaves in the body when given as a pill or a nasal spray. Eight healthy adults took both forms, and researchers measured drug levels, heart rate, and blood pressure over 24 hours. The goal was to better understand the drug's effects, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IMIM (Hospital del Mar Medical Research Institute)
Barcelona, 08003, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test